7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schündeln MM et al. | Impairment of bone health in pediatric patients with hemolytic anemia. | 2014 | PLoS ONE | pmid:25299063 |
| Moran CS et al. | Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse. | 2014 | Arterioscler. Thromb. Vasc. Biol. | pmid:25301844 |
| Holt V et al. | Identification of a subpopulation of marrow MSC-derived medullary adipocytes that express osteoclast-regulating molecules: marrow adipocytes express osteoclast mediators. | 2014 | PLoS ONE | pmid:25302610 |
| Movérare-Skrtic S et al. | Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. | 2014 | Nat. Med. | pmid:25306233 |
| Cardelli M and Aubin JE | ERRγ is not required for skeletal development but is a RUNX2-dependent negative regulator of postnatal bone formation in male mice. | 2014 | PLoS ONE | pmid:25313644 |
| pmid:25316684 | ||||
| Lee CJ et al. | Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. | 2015 | J. Atheroscler. Thromb. | pmid:25318352 |
| pmid:25323324 | ||||
| pmid:25323794 | ||||
| pmid:25333856 | ||||
| Arrigoni C et al. | Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. | 2014 | Mol. Cancer | pmid:25335447 |
| pmid:25354898 | ||||
| pmid:25362655 | ||||
| Samir SM and Malek HA | Effect of cannabinoid receptors 1 modulation on osteoporosis in a rat model of different ages. | 2014 | J. Physiol. Pharmacol. | pmid:25371528 |
| pmid:25373482 | ||||
| D'Abramo A et al. | Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis. | 2014 | Mediators Inflamm. | pmid:25374442 |
| Lv Y et al. | Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits. | 2014 | BMC Musculoskelet Disord | pmid:25377946 |
| pmid:25383958 | ||||
| Akiyama N et al. | Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation. | 2014 | J. Exp. Med. | pmid:25385757 |
| Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
| pmid:25406873 | ||||
| pmid:25415928 | ||||
| pmid:25433965 | ||||
| pmid:25438102 | ||||
| pmid:25442456 | ||||
| Estanislau IM et al. | Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. | 2015 | Br J Clin Pharmacol | pmid:25444240 |
| pmid:25446166 | ||||
| pmid:25446307 | ||||
| pmid:25446507 | ||||
| pmid:25450818 | ||||
| pmid:25453890 | ||||
| pmid:25460576 | ||||
| Rao M et al. | Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. | 2015 | Exp. Hematol. | pmid:25461255 |
| pmid:25461399 | ||||
| pmid:25464125 | ||||
| Jiang Y et al. | Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. | 2014 | J Transl Med | pmid:25471933 |
| pmid:25475449 | ||||
| pmid:25475457 | ||||
| pmid:25486133 | ||||
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| Kadlub N et al. | The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. | 2015 | J. Bone Miner. Res. | pmid:25491283 |
| pmid:25494659 | ||||
| pmid:25498379 | ||||
| pmid:25499997 | ||||
| pmid:25502845 | ||||
| MacMillan AK et al. | Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. | 2014 | Int J Nanomedicine | pmid:25506216 |
| Lin TH et al. | NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. | 2015 | Tissue Eng Part A | pmid:25518013 |
| pmid:25518897 | ||||
| pmid:25532817 | ||||
| pmid:25536123 | ||||
| pmid:25539196 | ||||
| Shen A et al. | Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. | 2014 | Medicine (Baltimore) | pmid:25546658 |
| Fu Y et al. | Involvement of the Ca²⺠signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. | 2015 | J. Vet. Sci. | pmid:25549213 |
| pmid:25554597 | ||||
| Ostrowska Z et al. | Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. | 2014 | Endokrynol Pol | pmid:25554611 |
| pmid:25557611 | ||||
| pmid:25572286 | ||||
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| Wang F et al. | Association analysis between g.18873C>T and g.27522G>A genetic polymorphisms of OPG and bone mineral density in Chinese postmenopausal women. | 2014 | Biomed Res Int | pmid:25580430 |
| pmid:25585180 | ||||
| pmid:25585925 | ||||
| pmid:25589510 | ||||
| Son GY et al. | Hypotonic stress induces RANKL via transient receptor potential melastatin 3 (TRPM3) and vaniloid 4 (TRPV4) in human PDL cells. | 2015 | J. Dent. Res. | pmid:25595364 |
| Ottewell PD et al. | OPG-Fc inhibits ovariectomy-induced growth of disseminated breast cancer cells in bone. | 2015 | Int. J. Cancer | pmid:25603921 |
| pmid:25607338 | ||||
| pmid:25609157 | ||||
| pmid:25618371 | ||||
| pmid:25618600 | ||||
| Dale MD et al. | Bone-remodeling transcript levels are independent of perching in end-of-lay white leghorn chickens. | 2015 | Int J Mol Sci | pmid:25625518 |
| pmid:25633918 | ||||
| pmid:25634035 | ||||
| Lanza D et al. | Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells. | 2015 | PLoS ONE | pmid:25635832 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Shi W et al. | Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes. | 2014 | Biosci Trends | pmid:25641178 |
| pmid:25643339 | ||||
| pmid:25645361 | ||||
| HaDuong JH et al. | Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis. | 2015 | Int. J. Cancer | pmid:25648303 |
| Dumnicka P et al. | Osteoprotegerin, trail and osteoprotegerin/trail ratio in patients at early phase of acute pancreatitis. | 2014 | Folia Med Cracov | pmid:25648306 |
| pmid:25660312 | ||||
| pmid:25663522 | ||||
| Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
| Chung CP et al. | A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study. | 2015 | Int J Mol Sci | pmid:25679449 |
| pmid:25684548 | ||||
| Yang X et al. | Effects of TGF-β1 on OPG/RANKL expression of cementoblasts and osteoblasts are similar without stress but different with mechanical compressive stress. | 2015 | ScientificWorldJournal | pmid:25685846 |
| Han J et al. | [Determination of bone metabolic marker levels in perio-implant crevicular fluid and analysis of dental implants stability by resonance frequency in the early stage of healing]. | 2015 | Beijing Da Xue Xue Bao | pmid:25686326 |
| pmid:25694056 | ||||
| pmid:25708645 | ||||
| Nagy V and Penninger JM | The RANKL-RANK Story. | 2015 | Gerontology | pmid:25720990 |
| pmid:25724681 | ||||
| de Molon RS et al. | OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice. | 2015 | J. Bone Miner. Res. | pmid:25727550 |
| Choe CH et al. | Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. | 2015 | FEBS Lett. | pmid:25728277 |
| Qiao B et al. | Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. | 2015 | Drug Des Devel Ther | pmid:25733814 |
| Xiong L et al. | Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. | 2015 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25733894 |
| Alwood JS et al. | Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. | 2015 | J. Interferon Cytokine Res. | pmid:25734366 |
| Shah M et al. | Local origins impart conserved bone type-related differences in human osteoblast behaviour. | 2015 | Eur Cell Mater | pmid:25738584 |
| Hung JY et al. | Tricetin, a dietary flavonoid, suppresses benzo(a)pyrene‑induced human non‑small cell lung cancer bone metastasis. | 2015 | Int. J. Oncol. | pmid:25738754 |
| pmid:25738879 | ||||
| Tsuruda T | Osteoprotegerin: osteo-vascular connection. | 2015 | J. Atheroscler. Thromb. | pmid:25740050 |
| pmid:25741581 | ||||
| pmid:25744169 |